Chiral Phosphine-Rhodium Complex for Tetra-Substituted Enamide Hydrogenation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current catalysts for enamide hydrogenation have limitations in substrate range and achieve only moderate yield and enantioselectivity, particularly for tetra-substituted α, β-alkyl cycloalkenamide compounds.

Innovation Solution

A metal complex is developed by complexing chiral phosphine ligands with transition metals, which serves as a catalyst for asymmetric catalytic hydrogenation, enabling the synthesis of chiral β-aryl amides with high optical purity and efficiently catalyzing the hydrogenation of tetra-substituted enamide compounds.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Adaptability or versatility

If existing catalysts are used for enamide hydrogenation, then the reaction can proceed, but the substrate range is limited and enantioselectivity is only moderate

Engineering Contradiction:
Improvesubstrate rangeVSAvoidenantioselectivity
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent modifies the ligand structure parameters by introducing specific substituents (R1 and R2 groups) at defined positions on the phosphine ligand framework. These parameter changes in ligand structure enable the catalyst to accommodate various substrate types while maintaining high enantioselectivity, resolving the contradiction between broad substrate range and high stereoselectivity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent creates a composite catalytic system by combining the specially designed chiral phosphine ligand with rhodium metal center. This composite structure integrates the electronic properties of the ligand with the catalytic activity of the metal, achieving both broad substrate scope and high enantioselectivity that neither component could achieve alone

Inventive Principle:
Principle #40Composite materials

2Manufacturing precision

If existing catalysts are used for asymmetric hydrogenation, then chiral amides can be synthesized, but the optical purity is limited and carrying capacity is low

Engineering Contradiction:
Improveoptical purityVSAvoidcarrying capacity
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent optimizes ligand parameters including steric bulk (R1, R2 substituents) and electronic properties to achieve optimal balance between catalyst stability and substrate binding. This parameter optimization enables the catalyst to maintain high optical purity (ee > 99%) while significantly increasing the substrate-to-catalyst ratio to 100,000:1, resolving the contradiction between precision and productivity

Inventive Principle:
Principle #35Parameter changes

3Productivity

If existing catalysts are used, then hydrogenation reaction can occur, but the carrying capacity of ligand is limited

Engineering Contradiction:
Improvecarrying capacityVSAvoidcatalytic efficiency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent modifies the ligand's steric and electronic parameters by introducing specific R1 and R2 groups that optimize the catalyst's interaction with substrates. These parameter changes enable the catalyst to maintain high turnover numbers and catalytic efficiency even at extremely low ligand loadings, achieving carrying capacity of 100,000:1 substrate-to-ligand ratio

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The metal complex achieves high optical purity (ee value > 99%) and significantly improves the carrying capacity of ligands, overcoming the limitations of existing catalysts and demonstrating strong economic practicability.

Implementation Method 1

the field of asymmetric hydrogenation has made great progress... achieved the asymmetric hydrogenation of tetra-substituted cycloalkenamides... using the catalytic system of Rh and Me-Pennphos... Bruneau et al. also tried asymmetric hydrogenation of tetra-substituted cycloalkenamide substrates via the catalytic system of Ru and Me-DuPhos or Me-BPE ligand

Methodology Applied
Scientific EffectCatalysis: Catalysis

Implementation Method 2

asymmetric hydrogenation of paraenamides... asymmetric hydrogenation of tetra-substituted cycloalkenamide... asymmetric hydrogenation of tetra-substituted enamide compounds

Methodology Applied
Scientific EffectHydrogenation: Hydrogenation

Data Source

PatentUS12110302B2Metal complex, intermediate, and preparation method and application thereof
Publication Date: 2024.10.08 SHANGHAI INST OF ORGANIC CHEM CHINESE ACAD OF SCI
  • US12110302B2 patent drawing
  • US12110302B2 patent drawing
  • US12110302B2 patent drawing

AI summary

Provided is a metal complex as represented by formula I. The metal complex may be used as a catalyst for asymmetric catalytic hydrogenation, is capable of efficiently catalyzing and synthesizing a series of chiral p-aryl amides having high optical purity, and is especially capable of asymmetrically catalyzing and hydrogenating a tetra-substituted enamide compound, chiral amides having high optical purity are synthesized, and the carrying amount of ligand may reach 100,000.